White label ELPA - ClinicalTrials.eu

Study Comparing Immediate and Extended Release Tacrolimus to Reduce Toxicity in Lung Transplant Patients

Not recruiting

3 1 1 1
Investigated Diseases:
- Lung transplant
Investigated Drugs:
- Tacrolimus
Study on the Safety and Effectiveness of Alpha1H for Adults with Non-Muscle Invasive Bladder Cancer Awaiting Tumor Removal Surgery

Not recruiting

1 1
Investigated Diseases:
- Bladder transitional cell carcinoma
Investigated Drugs:
- Alpha1H
Study on the Effectiveness of Cabotegravir and Rilpivirine for People with HIV-1 Who Have Not Responded Well to Oral Treatment

Not recruiting

3 1 1 1
Investigated Diseases:
- HIV infection
Investigated Drugs:
- Cabotegravir
- Rilpivirine
Study of Quizartinib with Chemotherapy for Adults with Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia

Not recruiting

3 1 1
Investigated Diseases:
- Acute myeloid leukaemia
Investigated Drugs:
+9
Study on the Effectiveness of Cup a 1 Immunotherapy for Patients with Moderate to Severe Allergic Rhinoconjunctivitis with or without Controlled Asthma

Not recruiting

3 1
Investigated Diseases:
- Conjunctivitis allergic
Study on the Safety and Effectiveness of Sargramostim with Daratumumab, Cyclophosphamide, Bortezomib, and Dexamethasone in Untreated Light Chain Amyloidosis Patients

Not recruiting

2 1 1 1
Investigated Diseases:
- Primary amyloidosis
Investigated Drugs:
Study on Improving Oral Cancer Surgery Using cRGD-ZW800-1 Fluorescent Imaging for Patients with Oral Cancer

Not recruiting

2 1 1
Investigated Diseases:
- Oral neoplasm
Investigated Drugs:
- Crgd-Zw800-1
Study on the Use of 18F-PSMA-1007, Piflufolastat (18F), and Gozetotide for Detecting Pelvic Lymph Node Invasion in Newly Diagnosed Prostate Cancer Patients

Not recruiting

3 1 1 1
Investigated Diseases:
- Prostate cancer
Investigated Drugs:
Study on Verapamil SR for Adults with Newly Diagnosed Type 1 Diabetes to Preserve Beta-Cell Function

Not recruiting

2 1 1
Investigated Drugs:
- Verapamil Hydrochloride
Study of Eciskafusp Alfa and BCG for Patients with High-Risk Bladder Cancer Not Responding to BCG Treatment

Not recruiting

1 1 1 1
Investigated Diseases:
- Bladder transitional cell carcinoma
Investigated Drugs:
- RO7284755
+1

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies